Introduction: Sinus pericranii is a vascular anomaly with extra- and intracranial venous connections. Sinus pericranii is categorized into 2 groups according to its contribution to the normal venous circulation. The accessory type sinus pericranii, which does not contribute to the normal major venous circulation, can be managed. Despite several proposed operative maneuvers, a standardized technique is yet to be established to control intraoperative bleeding. Case Presentation: A 2-week-old neonate underwent examination of a subcutaneous mass in the parieto-occipital region. The subcutaneous mass had a major venous connection to the superior sagittal sinus on ultrasonography. The subcutaneous mass was partially thrombolized on magnetic resonance imaging and was minimally enhanced on computed tomography venography. The subcutaneous mass seemed not to contribute to the normal venous circulation. Surgical removal of the subcutaneous mass was performed due to its increased size at the age of 1 year and 3 months. While subcutaneous mass was detached from the scalp, the major venous connection was manually compressed, and minor venous connections were easily detected. The intraoperative bleeding was controllable. The pathological diagnosis was sinus pericranii. The patient is now followed up in the outpatient clinic. No recurrence was seen 18 months after the surgery. Discussion/Conclusion: Intraoperative hemostasis is essential while sinus pericranii is detached from the cranium. Hemostatic agents such as bone wax or absorbable gelatin and heat coagulation seem to be useful. However, complicative hemorrhage concerning to the preceded technique has been also reported. As seen in our case, to detect minor shunting points between the sinus pericranii and the intracranial veins, the major venous connection was manually compressed. Intraoperative manual compression of a major venous connection of sinus pericranii can be an option to manage intraoperative bleeding.

1.
Gandolfo
C
,
Krings
T
,
Alvarez
H
,
Ozanne
A
,
Schaaf
M
,
Baccin
CE
, et al.
Sinus pericranii: diagnostic and therapeutic considerations in 15 patients
.
Neuroradiology
.
2007 Jun
;
49
(
6
):
505
14
. .
2.
Park
SC
,
Kim
SK
,
Cho
BK
,
Kim
HJ
,
Kim
JE
,
Phi
JH
, et al.
Sinus pericranii in children: report of 16 patients and preoperative evaluation of surgical risk
.
J Neurosurg Pediatr
.
2009 Dec
;
4
(
6
):
536
42
. .
3.
Pavanello
M
,
Melloni
I
,
Antichi
E
,
Severino
M
,
Ravegnani
M
,
Piatelli
G
, et al.
Sinus pericranii: diagnosis and management in 21 pediatric patients
.
J Neurosurg Pediatr
.
2015 Jan
;
15
(
1
):
60
70
. .
4.
Aburto-Murrieta
Y
,
Bonifacio-Delgadillo
D
,
Balderrama Bañares
J
,
Zenteno Castellanos
MA
.
Sinus pericranii: case report
.
Vasc Endovascular Surg
.
2011 Jan
;
45
(
1
):
103
5
. .
5.
Rizvi
M
,
Behari
S
,
Singh
RK
,
Gupta
D
,
Jaiswal
AK
,
Jain
M
, et al.
Sinus pericranii with unusual features: multiplicity, associated dural venous lakes and venous anomaly, and a lateral location
.
Acta Neurochir
.
2010 Dec
;
152
(
12
):
2197
204
. .
6.
Ellis
JA
,
Mejia Munne
JC
,
Feldstein
NA
,
Meyers
PM
.
Determination of sinus pericranii resectability by external compression during angiography: technical note
.
J Neurosurg Pediatr
.
2016
;
17
(
2
):
129
133
. .
7.
Ryorin
M
,
Morioka
T
,
Murakami
N
,
Suzuki
SO
,
Kawamura
N
.
Dynamic morphological changes of thrombosed lateral sinus pericranii revealed by serial magnetic resonance images
.
Childs Nerv Syst
.
2018 Jan
;
34
(
1
):
143
8
. .
8.
Ryu
JY
,
Lee
JH
,
Lee
JS
,
Lee
JW
,
Lee
SJ
,
Lee
JM
, et al.
Combined treatment of surgery and sclerotherapy for sinus pericranii
.
Arch Craniofac Surg
.
2020 Apr
;
21
(
2
):
109
13
. .
9.
Tamura
G
,
Ogiwara
H
,
Morota
N
.
Characteristics of recurrent congenital sinus pericranii: case report and review of the literature
.
Pediatr Neurosurg
.
2019
;
54
(
4
):
265
9
. .
10.
Manjila
S
,
Bazil
T
,
Thomas
M
,
Mani
S
,
Kay
M
,
Udayasankar
U
.
A review of extraaxial developmental venous anomalies of the brain involving dural venous flow or sinuses: persistent embryonic sinuses, sinus pericranii, venous varices or aneurysmal malformations, and enlarged emissary veins
.
Neurosurg Focus
.
2018 Jul
;
45
(
1
):
E9
. .
11.
Asano
K
,
Sobata
E
,
Kubo
O
.
Subepicranial varix mimicking sinus pericranii: usefulness of three-dimensional computed tomography angiography and bone window computed tomography: case report
.
Neurol Med Chir
.
2000 Sep
;
40
(
9
):
467
71
. .
12.
Azusawa
H
,
Ozaki
Y
,
Shindoh
N
,
Sumi
Y
.
Usefulness of MR venography in diagnosing sinus pericranii: case report
.
Radiat Med
.
2000 Jul–Aug
;
18
(
4
):
249
52
.
13.
Simonin
A
,
Martinerie
S
,
Levivier
M
,
Daniel
RT
.
Three-dimensional printing of a sinus pericranii model: technical note
.
Childs Nerv Syst
.
2017 Mar
;
33
(
3
):
499
502
. .
14.
Carpenter
JS
,
Rosen
CL
,
Bailes
JE
,
Gailloud
P
.
Sinus pericranii: clinical and imaging findings in two cases of spontaneous partial thrombosis
.
AJNR Am J Neuroradiol
.
2004 Jan
;
25
(
1
):
121
5
..
15.
Ohshima
T
,
Miyachi
S
,
Joko
M
,
Matsuo
N
,
Kawaguchi
R
,
Maejima
R
, et al.
Endovascular embolization of sinus pericranii using a plastic cup during glue injection: a case report
.
World Neurosurg
.
2019 Jan 10
.
16.
Ota
T
,
Waga
S
,
Handa
H
,
Nishimura
S
,
Mitani
T
.
Sinus pericranii
.
J Neurosurg
.
1975 Jun
;
42
(
6
):
704
12
. .
17.
Bollar
A
,
Allut
AG
,
Prieto
A
,
Gelabert
M
,
Becerra
E
.
Sinus pericranii: radiological and etiopathological considerations. Case report
.
J Neurosurg
.
1992 Sep
;
77
(
3
):
469
72
. .
18.
Jung
S
,
Lee
JK
,
Kim
SH
,
Kim
JH
,
Kang
SS
,
Lee
JH
.
Parietal sinus pericranii: case report and technical note
.
Surg Neurol
.
2000 Sep
;
54
(
3
):
270
3
; discussion 73. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.